[go: up one dir, main page]

UA97961C2 - Способ лечения и/или улучшения диссеминированного внутрисосудистого свертывания крови - Google Patents

Способ лечения и/или улучшения диссеминированного внутрисосудистого свертывания крови

Info

Publication number
UA97961C2
UA97961C2 UAA200904468A UAA200904468A UA97961C2 UA 97961 C2 UA97961 C2 UA 97961C2 UA A200904468 A UAA200904468 A UA A200904468A UA A200904468 A UAA200904468 A UA A200904468A UA 97961 C2 UA97961 C2 UA 97961C2
Authority
UA
Ukraine
Prior art keywords
therapy
therapeutic
intravascular coagulation
disseminated intravascular
amelioration method
Prior art date
Application number
UAA200904468A
Other languages
English (en)
Ukrainian (uk)
Inventor
Йосиказу АОКИ
Original Assignee
Асахи Касеи Фарма Корпорейшн
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Асахи Касеи Фарма Корпорейшн filed Critical Асахи Касеи Фарма Корпорейшн
Publication of UA97961C2 publication Critical patent/UA97961C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/7455—Thrombomodulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Изобретение касается способа лечения и/или улучшения диссеминированного внутрисосудистого свертывания крови (ДВС) и способа снижения вероятности смерти у пациентов, страдающих ДВС, путем введения тромбомодулина пациентам, страдающим ДВС, у которых активность антитромбина в плазме составляет 40 % или менее.
UAA200904468A 2006-10-06 2007-10-05 Способ лечения и/или улучшения диссеминированного внутрисосудистого свертывания крови UA97961C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006274573 2006-10-06
PCT/JP2007/069560 WO2008044631A1 (fr) 2006-10-06 2007-10-05 Agent thérapeutique et/ou améliorant pour la coagulation intravasculaire disséminée

Publications (1)

Publication Number Publication Date
UA97961C2 true UA97961C2 (ru) 2012-04-10

Family

ID=39282827

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200904468A UA97961C2 (ru) 2006-10-06 2007-10-05 Способ лечения и/или улучшения диссеминированного внутрисосудистого свертывания крови

Country Status (17)

Country Link
US (1) US20100152106A1 (ru)
EP (1) EP2062589A4 (ru)
JP (1) JP5579385B2 (ru)
KR (1) KR20090051777A (ru)
CN (1) CN101522206B (ru)
AU (1) AU2007305550B2 (ru)
BR (1) BRPI0720158A2 (ru)
CA (1) CA2665691A1 (ru)
CO (1) CO6160332A2 (ru)
HK (1) HK1130209A1 (ru)
IL (1) IL197509A (ru)
MX (1) MX2009003384A (ru)
MY (1) MY148565A (ru)
NZ (1) NZ575632A (ru)
RU (1) RU2433829C2 (ru)
UA (1) UA97961C2 (ru)
WO (1) WO2008044631A1 (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102216326A (zh) * 2008-11-12 2011-10-12 伊莱利利公司 凝血调节蛋白变体的组合物和使用方法
AU2019347406B9 (en) * 2018-09-28 2023-11-16 Asahi Kasei Pharma Corporation Medicament for mitigating conditions and/or suppressing onset of peripheral neuropathy induced by anti-malignant tumor agent
BR112021007460A2 (pt) * 2018-10-22 2021-11-03 Asahi Kasei Pharma Corp Medicamento para tratamento terapêutico e/ou melhora de um paciente com sepse
RU2716492C1 (ru) * 2019-05-14 2020-03-12 Федеральное Государственное Бюджетное Научное Учреждение "Федеральный Научно-Клинический Центр Реаниматологии И Реабилитологии" (Фнкц Рр) Способ регулирования активации нейтрофилов в модели in vitro

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988005053A1 (en) * 1987-01-08 1988-07-14 Asahi Kasei Kogyo Kabushiki Kaisha Peptide functioning to accelerate activation of protein c with thrombin
EP0285511B1 (en) 1987-04-01 1992-11-25 Mitsubishi Gas Chemical Company, Inc. Immunoassay of thrombomodulin
DK299087D0 (da) 1987-06-12 1987-06-12 Novo Industri As Proteins and derivatives thereof
JPS646219U (ru) 1987-06-30 1989-01-13
JPS6445398U (ru) 1987-09-11 1989-03-20
JPH0720997B2 (ja) 1988-08-29 1995-03-08 興和株式会社 新規なトロンビン結合性物質及びその製法
JPH0798840B2 (ja) 1988-12-27 1995-10-25 持田製薬株式会社 尿由来の抗血液疑固物質、その製法およびそれを含有する医薬組成物
US5202421A (en) * 1988-12-27 1993-04-13 Mochida Pharmaceutical Co., Ltd. Anticoagulant substance obtained from urine and process for the preparation thereof
JPH02255699A (ja) 1989-03-28 1990-10-16 Asahi Chem Ind Co Ltd 新規血液抗凝固物質及びその製法
US6063763A (en) * 1989-04-28 2000-05-16 Schering Aktiengesellschaft Protease-resistant thrombomodulin analogs
CA2022713A1 (en) 1989-08-11 1991-02-12 Nils U. Bang Human thrombomodulin derivatives
JPH03259084A (ja) 1990-03-06 1991-11-19 Kowa Co トロンビン結合性物質の製造法
AU643306B2 (en) * 1990-06-27 1993-11-11 Mochida Pharmaceutical Co., Ltd. Anticoagulant polypeptides
KR930008093B1 (ko) * 1990-08-03 1993-08-25 아사히가세이고오교 가부시끼가이샤 신규 폴리펩티드 및 이를 유효성분으로 하는 의약조성물
JPH05213998A (ja) 1990-08-03 1993-08-24 Asahi Chem Ind Co Ltd 新規なポリペプチド及びこれを有効成分とする 医薬組成物
CA2087271C (en) 1990-08-15 2009-03-24 Charles B. Glaser Superior thrombomodulin analogs for pharmaceutical use
JP3220174B2 (ja) 1990-12-12 2001-10-22 第一製薬株式会社 組換ヒトトロンボモジュリン誘導体
AU675422B2 (en) 1992-02-05 1997-02-06 David Richard Light Protease-resistant thrombomodulin analogs
JPH05310787A (ja) 1992-05-01 1993-11-22 Asahi Chem Ind Co Ltd 新規なポリペプチド
JPH06205692A (ja) 1993-01-08 1994-07-26 Asahi Chem Ind Co Ltd 新規な抗ヒトトロンボモジュリンモノクロ−ナル抗体およびその抗体を用いたヒトトロンボモジュリンの高感度測定方法
US5916874A (en) * 1994-04-20 1999-06-29 Asahi Kasei Kogyo Kabushiki Kaisha Method for treating liver injury
JP2824392B2 (ja) 1994-05-31 1998-11-11 旭化成工業株式会社 トロンビンによるプロテインｃの活性化を促進する作用を有するペプチドを含有する培養上澄液
JP3745805B2 (ja) 1995-10-24 2006-02-15 日本ケミカルリサーチ株式会社 トロンボモジュリンの精製方法
JP4157644B2 (ja) 1998-03-30 2008-10-01 旭化成ファーマ株式会社 高純度可溶性トロンボモジュリンの製造方法
JP2005519267A (ja) * 2002-02-27 2005-06-30 バイオメリュー・インコーポレイテッド 止血機能不全、重症感染及び全身性炎症反応症候群を診断し、監視するための方法
US7250168B2 (en) * 2002-05-01 2007-07-31 Bayer Schering Pharma Ag Tissue factor targeted thrombomodulin fusion proteins as anticoagulants

Also Published As

Publication number Publication date
US20100152106A1 (en) 2010-06-17
JP5579385B2 (ja) 2014-08-27
AU2007305550B2 (en) 2010-09-30
CA2665691A1 (en) 2008-04-17
BRPI0720158A2 (pt) 2014-05-20
JPWO2008044631A1 (ja) 2010-02-12
CN101522206B (zh) 2013-03-27
MX2009003384A (es) 2009-04-08
CN101522206A (zh) 2009-09-02
MY148565A (en) 2013-04-30
KR20090051777A (ko) 2009-05-22
RU2009117253A (ru) 2010-11-20
AU2007305550A1 (en) 2008-04-17
EP2062589A4 (en) 2010-07-28
IL197509A (en) 2015-06-30
CO6160332A2 (es) 2010-05-20
WO2008044631A1 (fr) 2008-04-17
RU2433829C2 (ru) 2011-11-20
NZ575632A (en) 2011-12-22
EP2062589A1 (en) 2009-05-27
HK1130209A1 (en) 2009-12-24
IL197509A0 (en) 2011-08-01

Similar Documents

Publication Publication Date Title
WO2009050506A3 (en) Combination 059
WO2006131392A8 (en) Pharmaceutical compositions of a neuroactive steroid and uses thereof
WO2008020027A3 (en) 2,5-dihydroxybenzene compounds for the treatment of skin cancer
WO2006085115A3 (en) Therapeutic uses of tomato extracts
MY173994A (en) Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
WO2007127273A3 (en) Methods and compositions for altering cell function
HK1086186A1 (en) Use of spongosine (2-methoxyadenosein) for preparing pharmaceutical for the treatment of pain
WO2010123569A3 (en) Immunonanotherapeutics providing a th1-biased response
TW200507830A (en) Bronchodilating β -agonist compositions and methods
WO2007131232A8 (en) Compositions and their uses directed to ptpr alpha
CA2529735A1 (en) Eicosapentaenoic acid for preventing or treating varicose veins of lower extremities
WO2007062093A3 (en) Combination therapy for the treatment of cancer comprising a metalloprotease inhibitor
WO2008052139A3 (en) Ultra low dose doxepin and methods of using the same to treat sleep disorders
NZ598906A (en) Vesicular formulations
WO2009074827A3 (en) Combination comprising a mek inhibitor and an aurora kinase inhibitor
WO2007136845A3 (en) Low-dose doxepin for treatment of sleep disorders in elderly patients
TW200724146A (en) Use of LGG in the manufacture of a medicament for the treatment, prevention or reduction of systemic inflammation in a formula-fed infant
UA97961C2 (ru) Способ лечения и/или улучшения диссеминированного внутрисосудистого свертывания крови
WO2007130501A3 (en) Combination therapy for treatment of cancer
WO2008045378A3 (en) Treatment of infant hyperbilirubinemia using low dosages of stannsoporfin
WO2007133796A3 (en) Methods and compositions for treatment of sleep apnea comprising administration of an endothelin antagonist
WO2008125800A3 (en) Mmp activated vascular disrupting agents
WO2007041388A3 (en) Prevention and treatment of hearing disorders
TW200420290A (en) Methods for the treatment, prevention and management of macular degeneration
WO2004058329A3 (en) Ester combination local anesthetic